July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
CGRP and PACAP induced vasodilation in the porcine retinal vasculature
Author Affiliations & Notes
  • Kristian Agmund Haanes
    Department of Clinical Experimental Research , Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
  • Frank W Blixt
    Department of Clinical Sciences, Lund University, Lund, Sweden
  • Vadim Fedulov
    Department of Clinical Experimental Research , Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
  • Majid Sheykhzade
    Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Karin D Sörensen
    Department of Clinical Experimental Research , Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
  • Lars Edvinsson
    Department of Clinical Experimental Research , Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
    Department of Clinical Sciences, Lund University, Lund, Sweden
  • Karin Warfvinge
    Department of Clinical Experimental Research , Copenhagen University Hospital, Rigshospitalet, Glostrup, Denmark
    Department of Clinical Sciences, Lund University, Lund, Sweden
  • Footnotes
    Commercial Relationships   Kristian Agmund Haanes, None; Frank Blixt, None; Vadim Fedulov, None; Majid Sheykhzade, None; Karin D Sörensen, None; Lars Edvinsson, None; Karin Warfvinge, None
  • Footnotes
    Support  Lundbeckfoundation - Grant of Excellence
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2643. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kristian Agmund Haanes, Frank W Blixt, Vadim Fedulov, Majid Sheykhzade, Karin D Sörensen, Lars Edvinsson, Karin Warfvinge; CGRP and PACAP induced vasodilation in the porcine retinal vasculature. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2643.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : CGRP (Calcitonin Gene-Related Peptide) and PACAP (Pituitary Adenylate Cyclase-Activating Peptide) are peptides with strong vasoactive effects. Retinal vasculature is known to be important in retinal ischemia, where vasodilating peptides could be a potential treatment. In addition, both peptides are known to be involved in migraine, a disease with vascular symptoms such as photosensitivity and aura, although they are hypothesized to also involve changes in the CNS. We therefore set out to investigate the potential effect of CGRP on the porcine retinal vasculature, and if the retinal and its vasculature could have sensory innervation.

Methods : We studied the porcine retinal vasculature and the ophthalmic artery using a wire myograph. Concentration dependence curves to CGRP and PACAP was obtained. We furthermore performed retrograde tracer experiments, where the dye DiI was injected intravitreal in male Sprague Dawley rats, where we traced the marker back to the trigeminal ganglion.

Results : CGRP was shown to be a strong vasodilator ( Emax dilation 83 ± 5 %) of the ophthalmic artery, whereas PACAP was very weakly vasodilating ( Emax dilation 37 ± 22 %). In contrast, the retinal vasculature was slightly more sensitive to PACAP (Emax dilation 40 ± 12 %) than CGRP (Emax dilation 29 ± 9 %). Our retrograde tracing experiment showed that there are indeed sensory neurons that innervate, the retina, and our next step is confirming the peptide identity of these neurons.

Conclusions : The ophthalmic artery, dilated strongly in response to CGRP. More interestingly, the porcine retinal vasculature relaxed in response to both PACAP and CGRP. We show that nerves originating from the trigeminal ganglion innervate the rat retina, and could therefore be the source of the sensory and vasoactive peptides. Nevertheless, innervation of the retinal vasculature is controversial, and there are other experimental data showing that CGRP is present locally in the retina, which could also be the peptide source. We conclude that CGRP and PACAP has vasoactive effects in the retinal vasculature, which could contribute to understanding migraine symptoms and in addition, be a potential treatment for ischemic eye disease.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×